InsidersTradesSigma
Track the 艾德生物 stock price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 艾德生物 has logged 3 insider filings. Market capitalisation: €6.7bn. The latest transaction was disclosed on 8 August 2023 (Purchase). Among the most active insiders: 杜立威. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
艾德生物是一家专注于健康和制药领域的公司，致力于开发生物制药解决方案。该公司在XSHE市场上市。